| Advanced glycation end products in isoproterenol-induced acute myocardial infarction T Timercan, I Şveţ, V Pantea, A Ambros, L Lîsîi Medicine and pharmacy reports 92 (3), 235, 2019 | 9 | 2019 |
| Particularitățile metabolismului acizilor grași în miocard T Timercan, S Stratulat, T Branişte, L Lîsîi Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale 54 (2), 78-83, 2017 | 5 | 2017 |
| Malonyl dialdehyde in isoproterenol-induced acute myocardial infarction T TIMERCAN, T Branishte, L LÎSÎI The Medical-Surgical Journal 123 (3), 407-412, 2019 | 4 | 2019 |
| Assessment of ischemia modified albumin serum level in isoproterenol-induced myocardial infarction T Timercan, V Timercan Biological Markers in Fundamental and Clinical Medicine, 2017 | 4 | 2017 |
| Malondialdehyde variations in experimental myocardial infarction T Timercan, V Timercan Biological Markers in Fundamental and Clinical Medicine/Collection of …, 2018 | 3 | 2018 |
| Evaluarea unor modificări metabolice (glucidice, lipidice) și inflamatorii în infarct miocardic acut–studiu preclinic experimental T Timercan | 1 | 2020 |
| Strengthening the actions to prevent doping among athletes in the Republic of Moldova T Timercan, A Jucov, S Cebanu One Health and Risk Management, 82-82, 2023 | | 2023 |
| Schimbările climatice ca factori de risc cardiovascular A Timercan, T Timercan, C Lazăr One Health and Risk Management, 36-36, 2023 | | 2023 |
| Asocierea schimbărilor climatice cu procesele neurodegenerative C Lazăr, O Tagadiuc, T Timercan One Health and Risk Management, 38-38, 2023 | | 2023 |
| The safety of athletes in the administration of medicinal substances T Timercan Sănătate Publică, Economie şi Management în Medicină 94 (1), 41-44, 2023 | | 2023 |
| Doping-free lifestyle and health care trends offered for athletes T Timercan, A Jucov Sănătate Publică, Economie şi Management în Medicină 94 (1), 35-40, 2023 | | 2023 |
| Management of heart failure–a challenge for the twenty-first century C Slanina, T Timercan One Health and Risk Management, 48-48, 2023 | | 2023 |
| Meldonium–a new challenging subject in the performance sport T Timercan One Health and Risk Management, 42-42, 2023 | | 2023 |
| Assessment of anti-doping knowledge of medical students S Cebanu, A Jucov, T Timercan One Health and Risk Management, 38-38, 2023 | | 2023 |
| Experimental model of cardiac ischemia T Timercan, C Lazăr Perspectives of the Balkan medicine in the post COVID-19 era, 20-20, 2023 | | 2023 |
| Postreperfusion tissue metabolic changes in ovarian torsion C Lazăr, T Timercan Perspectives of the Balkan medicine in the post COVID-19 era, 19-19, 2023 | | 2023 |
| Impact of COVID-19 pandemic on athletes’ health A Jucov, V Federiuc, T Timercan Revista de Ştiinţe ale Sănătăţii din Moldova 29 (3 An. 1), 105-105, 2022 | | 2022 |
| Therapeutic use exemptions T Timercan, A Jucov Revista de Ştiinţe ale Sănătăţii din Moldova 29 (3 An. 1), 102-102, 2022 | | 2022 |
| Impactul pandemiei COVID-19 asupra sănătății sportivilor A Jucov, V Federiuc, T Timercan Revista de Științe ale Sănătății din Moldova= Moldovan Journal of Health …, 2022 | | 2022 |
| Scutirea pentru uz terapeutic T Timercan, A Jucov Revista de Științe ale Sănătății din Moldova= Moldovan Journal of Health …, 2022 | | 2022 |
Artiom JucovSUMPh Nicolae TestemitanuVerified email at usmf.md
